Table 5 Prognostic factors of pancreatic cancer patients in cause-specific survival of patients with pancreatic cancers after repeat pancreatectomy
Clinico-pathological parameters | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
n = 24 | HR (95% CI) | p value | HR (95% CI) | p value | |
Preoperative CA19–9 (≥ 100/< 100) (U/mL) | 13 / 11 | 0.79 (0.27–2.91) | 0.85 | ||
NLR (≥ 3.0/< 3.0) | 14 / 10 | 0.94 (0.30–3.20) | 0.92 | ||
LMR (≥ 3.3/< 3.3) | 16 / 8 | 0.27 (0.08–0.89) | 0.033* | 0.07 (0.01–0.37) | 0.0013* |
Intervals from 1st to 2nd operation (≥ 24 m/< 24 m) | 17 / 7 | 0.59 (0.18–2.21) | 0.40 | ||
PVR (+/−) | 3 / 21 | 7.84 (1.53–36.03) | 0.017* | 3.86 (0.62–25.72) | 0.14 |
Arterial resection (+/−) | 5 / 19 | 4.20 (1.05–15.19) | 0.043* | 1.90 (0.38–9.66) | 0.43 |
pN (+/−) | 10 / 14 | 4.12 (1.26–15.90) | 0.019* | 5.53 (1.04–37.45) | 0.045* |
Curability (R0/1) | 17 / 7 | 1.20 (0.36–5.44) | 0.78 | ||
Postoperative CA19–9 (≥ 37/< 37) (U/mL) | 10 / 14 | 1.74 (0.54–5.58) | 0.34 | ||
Decrease rate of CA19–9 (≥ 70/< 70) (%) | 13 / 11 | 0.37 (0.10–1.18) | 0.093 | 0.32 (0.05–1.56) | 0.16 |
Adjuvant chemotherapy after RP (+/−) | 16 / 8 | 0.88 (0.27–3.36) | 0.84 | ||